Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


3 Antiviral Res
1 J Immunol
1 J Infect
2 J Virol
1 J Virol Methods
1 Lancet Infect Dis
1 N Engl J Med
6 PLoS One
5 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antiviral Res

  1. PICHON M, Gaymard A, Josset L, Valette M, et al
    Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis.
    Antiviral Res. 2017 Aug 2. pii: S0166-3542(17)30431.
    PubMed     Text format     Abstract available

  2. ZHANG S, Sun F, Ren T, Duan Y, et al
    Immunogenicity of an influenza virus-vectored vaccine carrying the hepatitis C virus protein epitopes in mice.
    Antiviral Res. 2017 Aug 1. pii: S0166-3542(16)30742.
    PubMed     Text format     Abstract available

  3. HU Y, Zhang J, Musharrafieh RG, Ma C, et al
    Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
    Antiviral Res. 2017;145:103-113.
    PubMed     Text format     Abstract available

    J Immunol

  4. MALLOY AM, Ruckwardt TJ, Morabito KM, Lau-Kilby AW, et al
    Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates.
    J Immunol. 2017;198:394-403.
    PubMed     Text format     Abstract available

    J Infect

  5. FENG Y, Gao L, Miao J, Zhang M, et al
    Human infection with a novel H7N9 avian influenza virus in Yunnan, China.
    J Infect. 2017 Aug 7. pii: S0163-4453(17)30258.
    PubMed     Text format    

    J Virol

  6. BERTRAN K, Lee DH, Pantin-Jackwood MJ, Spackman E, et al
    Pathobiology of clade H5Nx high pathogenicity avian influenza virus infections in minor gallinaceous poultry supports early backyard flock introductions in Western U.S., 2014-2015.
    J Virol. 2017 Aug 9. pii: JVI.00960-17. doi: 10.1128/JVI.00960.
    PubMed     Text format     Abstract available

  7. CHLANDA P, Mekhedov E, Waters H, Sodt A, et al
    Palmitoylation contributes to membrane curvature in Influenza A virus assembly and hemagglutinin-mediated membrane fusion.
    J Virol. 2017 Aug 9. pii: JVI.00947-17. doi: 10.1128/JVI.00947.
    PubMed     Text format     Abstract available

    J Virol Methods

  8. CHEN W, Zhong Y, Su R, Qi H, et al
    N-glycan profiles in H9N2 avian influenza viruses from chicken eggs and human embryonic lung fibroblast cells.
    J Virol Methods. 2017 Aug 7. pii: S0166-0934(17)30155.
    PubMed     Text format     Abstract available

    Lancet Infect Dis

  9. SINGANAYAGAM A, Zambon M, Lalvani A, Barclay W, et al
    Urgent challenges in implementing live attenuated influenza vaccine.
    Lancet Infect Dis. 2017 Aug 2. pii: S1473-3099(17)30360.
    PubMed     Text format     Abstract available

    N Engl J Med

  10. JACKSON ML, Chung JR, Jackson LA, Phillips CH, et al
    Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.
    N Engl J Med. 2017;377:534-543.
    PubMed     Text format     Abstract available

    PLoS One

  11. PARK JY, Kim BJ, Lee EJ, Park KS, et al
    Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel.
    PLoS One. 2017;12:e0170592.
    PubMed     Text format     Abstract available

  12. OMAR S, Clarke R, Abdullah H, Brady C, et al
    Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells.
    PLoS One. 2017;12:e0171681.
    PubMed     Text format     Abstract available

  13. CHEN WA, Zhang J, Hall KM, Martin CB, et al
    Addition of alphaGal HyperAcute technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
    PLoS One. 2017;12:e0182683.
    PubMed     Text format     Abstract available

  14. NGUYEN LT, Nakaishi K, Motojima K, Ohkawara A, et al
    Rapid and broad detection of H5 hemagglutinin by an immunochromatographic kit using novel monoclonal antibody against highly pathogenic avian influenza virus belonging to the genetic clade
    PLoS One. 2017;12:e0182228.
    PubMed     Text format     Abstract available

  15. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    PubMed     Text format     Abstract available

  16. LEE HJ, Lee JY, Park MH, Kim JY, et al
    Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
    PLoS One. 2017;12:e0169139.
    PubMed     Text format     Abstract available


  17. CHRISTIAN LM, Beverly C, Mitchell AM, Karlsson E, et al
    Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30686.
    PubMed     Text format     Abstract available

  18. VILLANUEVA-CABEZAS JP, Coppo MJC, Durr PA, McVernon J, et al
    Vaccine efficacy against Indonesian Highly Pathogenic Avian Influenza H5N1: systematic review and meta-analysis.
    Vaccine. 2017 Aug 2. pii: S0264-410X(17)30967.
    PubMed     Text format     Abstract available

  19. MELIDOU A, Broberg E
    Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)30965.
    PubMed     Text format     Abstract available

  20. SUZUKI T, Ainai A, Hasegawa H
    Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)31019.
    PubMed     Text format     Abstract available

  21. OHFUJI S, Kobayashi M, Ide Y, Egawa Y, et al
    Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine.
    Vaccine. 2017 Aug 4. pii: S0264-410X(17)31018.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.